Alpha1-chimaerin, a Rac1 GTPase-activating protein, is expressed at reduced mRNA levels in the brain of Alzheimer's disease patients

被引:10
|
作者
Kato, Tomoko [1 ]
Konishi, Yoshihiro [2 ]
Shimohama, Shun [3 ]
Beach, Thomas G. [4 ]
Akatsu, Hiroyasu [5 ]
Tooyama, Ikuo [1 ]
机构
[1] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 5202192, Japan
[2] Nishi Tottori Natl Hosp, Dept Clin Res, Tottori 6890202, Japan
[3] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan
[4] Banner Sun Hlth Res Inst, Sun City, AZ 85372 USA
[5] Nagoya City Univ, Grad Sch Med Sci, Dept Community Based Med Educ, Nagoya, Aichi 4678601, Japan
关键词
Alzheimer's disease; alpha; 1-chimaerin; Rac1; In situ hybridization; Real-time PCR; NEUROFIBRILLARY TANGLES; PYRAMIDAL NEURONS; NUCLEUS BASALIS; SPINE DENSITY; N-CHIMAERIN; KINASE; CDK5; HYPOTHESIS; INCREASES; PATHOLOGY;
D O I
10.1016/j.neulet.2015.02.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alpha1-chimaerin is a GTPase-activating protein (GAP) for Rac1, a member of the Rho small GTPase family, whose action leads to the inactivation of Rac1. Rac1 activity is upregulated in Alzheimer's disease, but little is known about the role of alpha 1-chimaerin. In this study, we investigated the expression and localization of alpha 1-chimaerin mRNA in postmortem human brains from patients with Alzheimer's disease and control subjects. In situ hybridization studies demonstrated that alpha 1 -chimaerin was expressed by neurons in the neo-cortex of the temporal lobe and the hippocampus of both controls and Alzheimer's disease cases, with the signal intensity dramatically decreased in patients with Alzheimer's disease. Realtime PCR analysis confirmed a significant reduction of alpha 1-chimaerin mRNA expression in the temporal cortex of Alzheimer's disease cases. In contrast, alpha 2-chimaerin mRNA levels showed no significant difference between the groups. The present study showed reduced alpha 1-chimaerin expression in the brain of Alzheimer's disease cases, suggesting a role in the upregulation of Rac1 activity during the disease process. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [31] Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients
    Bram, Jessyka Maria de Franca
    Talib, Leda Leme
    Joaquim, Helena Passarelli Giroud
    Sarno, Tamires Alves
    Gattaz, Wagner Farid
    Forlenza, Orestes Vicente
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2019, 269 (08) : 963 - 972
  • [32] Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease
    Davidsson, P
    Bogdanovic, N
    Lannfelt, L
    Blennow, K
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (04) : 243 - 250
  • [33] Signals are Required by HSV-1 Infected Neurons to Increase the Amount of Aβ Protein in the Brain of Alzheimer's Disease Patients
    Sun, Haohan
    BIOPHYSICAL SOCIETY OF GUANGDONG PROVINCE ACADEMIC FORUM: PRECISE PHOTONS AND LIFE HEALTH, PPLH 2022, 2023, 12603
  • [34] Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid- levels in brain
    Henderson, Benjamin W.
    Gentry, Erik G.
    Rush, Travis
    Troncoso, Juan C.
    Thambisetty, Madhav
    Montine, Thomas J.
    Herskowitz, Jeremy H.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 (04) : 525 - 531
  • [35] The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
    Dursun, Erdinc
    Gezen-Ak, Duygu
    Hanagasi, Hasmet
    Bilgic, Basar
    Lohmann, Ebba
    Ertan, Sibel
    Atasoy, Irem L.
    Alaylioglu, Merve
    Araz, Omur Selin
    Onal, Burak
    Gunduz, Aysegul
    Apaydin, Hulya
    Kiziltan, Gunes
    Ulutin, Turgut
    Gurvit, Hakan
    Yilmazer, Selma
    JOURNAL OF NEUROIMMUNOLOGY, 2015, 283 : 50 - 57
  • [36] C-Reactive Protein, Complement Component C1q and Homocysteine Levels in Patients with Alzheimer's Disease
    Zhao, X.
    Zhu, X. Q.
    Li, X. L.
    Wang, M.
    Zhao, M. D.
    Bu, X. X.
    Liu, W. S.
    Yang, Z.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S649 - S649
  • [37] The Levels of Leptin, Cystatin C, Neuropilin-1 and Tau Protein in Relation to Dietary Habits in Patients with Alzheimer's Disease
    Bogdan, Sylwia
    Puscion-Jakubik, Anna
    Klimiuk, Katarzyna
    Socha, Katarzyna
    Kochanowicz, Jan
    Gorodkiewicz, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [38] Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1
    Bacchetti, Tiziana
    Vignini, Arianna
    Giulietti, Alessia
    Nanetti, Laura
    Provinciali, Leandro
    Luzzi, Simona
    Mazzanti, Laura
    Ferretti, Gianna
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 46 (01) : 179 - 186
  • [39] Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model
    Mashkani, Seyed Mostafa Hosseinpour
    Bishop, David P.
    Westerhausen, Mika T.
    Adlard, Paul A.
    Golzan, S. Mojtaba
    METALLOMICS, 2024, 16 (12)
  • [40] Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease:: peripheral inflammation or signals from the brain?
    Licastro, F
    Pedrini, S
    Caputo, L
    Annoni, G
    Davis, LJ
    Ferri, C
    Casadei, V
    Grimaldi, LME
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 103 (01) : 97 - 102